The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multicenter randomized controlled trial of esophagectomy with or without prophylactic supraclavicular node dissection: A phase III trial (JCOG2013, MODERN3).
 
Shigeru Tsunoda
Honoraria - Abbott Japan; Asahi Kasei; Covidien/Medtronic; Ethicon/Johnson & Johnson; Kaken Pharmaceutical; Miyarisan Pharmaceutical
 
Yasuhiro Tsubosa
No Relationships to Disclose
 
Keita Sasaki
No Relationships to Disclose
 
Ryunosuke Machida
No Relationships to Disclose
 
Hiroyuki Daiko
No Relationships to Disclose
 
Ken Kato
Honoraria - BMS; Lilly; Ono Pharmaceutical
Consulting or Advisory Role - Bayer; BeiGene; MSD; Oncolys BioPharma; Ono Pharmaceutical
Speakers' Bureau - Bristol-Myers Squibb Japan; MSD; Ono Pharmaceutical
Research Funding - AstraZeneca (Inst); Bayer (Inst); Beigene (Inst); Chugai Pharma (Inst); MSD Oncology (Inst); Ono Pharmaceutical (Inst); Shionogi (Inst); Taiho Pharmaceutical (Inst)
 
Yuko Kitagawa
Honoraria - Asahi Kasei; AstraZeneca Japan; Bristol-Myers Squibb K.K.; Chugai Pharma; Ethicon; Kaken Pharmaceutical; MSD K.K.; Nippon Covidien; Olympus; Ono Pharmaceutical; Otsuka; Shionogi; Smith & Nephew; Taiho Pharmaceutical
Consulting or Advisory Role - Bristol-Myers Squibb K.K.; Ono Pharmaceutical
Research Funding - Asahi Kasei (Inst); Chugai Pharma (Inst); EA Pharma (Inst); Eisai (Inst); Kaken Pharmaceutical (Inst); Kyouwa Hakkou Kirin Co., Ltd. (Inst); Medicon (Inst); Nihon Pharma (Inst); Nippon Covidien (Inst); Ono Pharmaceutical (Inst); Otsuka (Inst); Otsuka (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Teijin Pharma (Inst); TSUMURA & CO. (Inst); Yakult Honsha (Inst)